Home>Topics>Finance>Food>Food And Drug Administration

Food And Drug Administration

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. BRIEF-Implanet gets CE mark and FDA clearance for new JAZZ diameters

    Headlines

    Tue, 19 May 2015

    * Receives CE mark and FDA clearance in United States for new JAZZ diameters

  2. To fight superbugs, FDA seeks detailed data on animal antimicrobials

    Headlines

    Tue, 19 May 2015

    May 19 (Reuters) - The U.S Food and Drug Administration said it is asking drugmakers for data on antimicrobials sold for use in each food animal, such as cows and chickens, as part of efforts to combat antibiotic-resistant bacteria.

  3. FDA approves longer-acting version of J&J's schizophrenia drug

    Headlines

    Tue, 19 May 2015

    May 19 (Reuters) - The U.S. Food and Drug Administration approved a longer-acting version of Johnson & Johnson's schizophrenia treatment, developed by the company's Janssen Pharmaceuticals unit.

  4. BRIEF-Roche U.S. FDA grants waiver for cobas Strep A test

    Headlines

    Tue, 19 May 2015

    * Roche says the U.S. Food and Drug Administration has granted CLIA (Clinical Laboratory Improvement Amendments) waiver for the cobas Strep A test for use on the cobas Liat System Further company coverage: (Reporting By Zurich Newsroom)

  5. UPDATE 2-U.S. FDA warns on newer class of type 2 diabetes drugs

    Headlines

    Fri, 15 May 2015

    May 15 (Reuters) - The U.S. Food and Drug Administration on Friday warned that a widely used newer class of type 2 diabetes drugs sold by AstraZeneca, Johnson & Johnson and Eli Lilly in partnership...

  6. U.S. FDA warns on newer class of type 2 diabetes drugs

    Headlines

    Fri, 15 May 2015

    May 15 (Reuters) - The U.S. Food and Drug Administration on Friday warned that a widely used newer class of type 2 diabetes drug sold by AstraZeneca, Johnson & Johnson and Eli Lilly in partnership...

  7. U.S. class action asserts India's Ranbaxy manipulated FDA rules

    Headlines

    Thu, 14 May 2015

    MUMBAI, May 14 (Reuters) - Indian generic drugmaker Ranbaxy Laboratories Ltd has been sued in a district court in the United States for allegedly manipulating U.S. Food and Drug Administration rules for years to keep rival generic drugs out of the market.

  8. BRIEF- FDA confirms that Cytotools can now request for clinical trial of DermaPro in US

    Headlines

    Wed, 13 May 2015

    * Successful dialogue with US food and drug administration ( FDA ) on the extension of the clinical testing program of DermaPro for the treatment of leg ulcers in the U.S.

  9. BioMarin's 1Q Results Supported by Strong Vimizim Launch; Drisapersen Approval Could Come Late 2015

    Commentary

    Wed, 13 May 2015

    patients on therapy; we remain cautious on Kuvan growth, as generic competition could enter as early as 2017. BioMarin filed for FDA approval of Duchenne muscular dystrophy drug drisapersen in April, and drisapersen's approval (which we expect in late 2015

  10. BRIEF-Lifewatch Mobile Cardiac Telemetry Patch application filed with the U.S. FDA

    Headlines

    Wed, 13 May 2015

    * Lifewatch Mobile Cardiac Telemetry Patch application filed with the U.S. FDA Source text for Eikon: Further company coverage: (Gdynia Newsroom)

« Prev12345Next »
Content Partners